| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/14/2010 | EP2173722A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 04/14/2010 | EP2173354A1 Quinoxaline derivatives as pi3 kinase inhibitors |
| 04/14/2010 | EP1919869B1 Indole derivatives as ppar activators |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1599201B1 Selective non-steroidal glucocorticoid receptor modulators |
| 04/14/2010 | EP1537078B1 Indoles having anti-diabetic activity |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | EP1294922B1 Treating cancer using organelle crystallizing agents |
| 04/14/2010 | CN1995036B Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative |
| 04/14/2010 | CN101693709A Bicyclic amides as kinase inhibitors |
| 04/14/2010 | CN101693708A Azasugar compound containing aryl and preparation process and application thereof |
| 04/14/2010 | CN101693697A Pyrizdazine derivatives and their use as therapeutic agents |
| 04/14/2010 | CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 04/13/2010 | US7696356 heating a mixture of 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one, an aldehyde and HCl (mineral acid) to provide 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one; and isolating the 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one ( without using secondary amine catalyst) |
| 04/13/2010 | US7696234 Histamine H3 receptor agents, preparation and therapeutic uses |
| 04/13/2010 | US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 04/13/2010 | US7696227 Small-molecule inhibitors of the androgen receptor |
| 04/13/2010 | US7696226 HIV protease inhibiting compounds |
| 04/13/2010 | US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives |
| 04/13/2010 | US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 04/13/2010 | US7696210 Gonadotropin releasing hormone receptor antagonists |
| 04/13/2010 | US7696207 Therapeutic agents useful for treating pain |
| 04/13/2010 | US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/13/2010 | US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders |
| 04/13/2010 | US7695643 Long wavelength shifted benzotriazole UV-absorbers and their use |
| 04/13/2010 | CA2474219C Dihydrobenzodiazepin-2-one derivatives iii |
| 04/13/2010 | CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/08/2010 | WO2010039982A1 Crth2 modulators |
| 04/08/2010 | WO2010039947A1 Novel compounds as calcium channel blockers |
| 04/08/2010 | WO2010039793A1 Hepatitis c virus inhibitors |
| 04/08/2010 | WO2010039789A1 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 04/08/2010 | WO2010039668A2 Inhibitors of cyclin kinase inhibitor p21 |
| 04/08/2010 | WO2010039545A2 1,2-benzisothiazolinone and isoindolinone derivatives |
| 04/08/2010 | WO2010039518A2 Tricyclic carbamate jak inhibitors |
| 04/08/2010 | WO2010038948A2 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders |
| 04/08/2010 | WO2010038081A2 Heterocyclic derivatives and methods of use thereof |
| 04/08/2010 | WO2010038060A1 Heterocyclic jak kinase inhibitors |
| 04/08/2010 | WO2010037727A1 Piperazine compounds with herbicidal effect |
| 04/08/2010 | WO2010037339A1 Aminoquinazoline derivatives and their salts with antineoplastic activity |
| 04/08/2010 | WO2010037225A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/08/2010 | WO2010037172A1 Antioxidant compounds and methods of their use |
| 04/08/2010 | WO2010005692A3 Insecticidal cyclic carbonyl amidines |
| 04/08/2010 | US20100087658 Methods and intermediates for synthesis of selective dpp-iv inhibitors |
| 04/08/2010 | US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors |
| 04/08/2010 | US20100087639 Process for the preparation of tertiary n-allyl sterically hindered amines |
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100087467 Compositions Useful As Inhibitors of Protein Kinases |
| 04/08/2010 | US20100087464 Protein kinase inhibitors and methods for using thereof |
| 04/08/2010 | US20100087461 Arylamide pyrimidone compounds |
| 04/08/2010 | US20100087460 Arylamide pyrimidone derivatives |
| 04/08/2010 | US20100087448 Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases |
| 04/08/2010 | US20100087446 2-substituted indole derivatives as calcium channel blockers |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087440 Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use |
| 04/08/2010 | US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity |
| 04/08/2010 | US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 04/08/2010 | US20100087423 New benzamide derivatives as bradykinin antagonists |
| 04/08/2010 | US20100087396 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 04/08/2010 | US20100087360 Heterocycle-substituted benzimidazole derivative |
| 04/08/2010 | CA2738828A1 Novel compounds |
| 04/08/2010 | CA2738799A1 Antioxidant compounds and methods of their use |
| 04/08/2010 | CA2738663A1 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 04/08/2010 | CA2738348A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/08/2010 | CA2738314A1 1,2-benzisothiazolinone and isoindolinone derivatives |
| 04/08/2010 | CA2737480A1 Novel compounds as calcium channel blockers |
| 04/08/2010 | CA2737217A1 Heterocyclic jak kinase inhibitors |
| 04/08/2010 | CA2736258A1 Tricyclic carbamate jak inhibitors |
| 04/07/2010 | EP2172559A1 Screening method |
| 04/07/2010 | EP2172461A1 Di(arylamino)aryl compound |
| 04/07/2010 | EP2172460A1 Compositions useful as inhibitors of JAK and other protein kinases |
| 04/07/2010 | EP2172457A2 Fredericamycin derivatives |
| 04/07/2010 | EP2172455A1 Oxime ester photoinitiators |
| 04/07/2010 | EP2170870A1 Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| 04/07/2010 | EP2170869A1 Alcohols containing imide moieties and reactive oligomers prepared therefrom |
| 04/07/2010 | EP2170868A1 An improved process for the preparation of candesartan cilexetil |
| 04/07/2010 | EP2170867A1 Protein kinase inhibitors and methods for using thereof |
| 04/07/2010 | EP2170866A1 Phthalazine compounds, compositions and methods of use |
| 04/07/2010 | EP2170863A2 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 04/07/2010 | EP2170860A2 Benzimidazole derivatives |
| 04/07/2010 | EP2170848A1 Pyrazinone derivatives and their use in the treatment of lung diseases |
| 04/07/2010 | EP2170846A2 Substituted piperazines as cb1 antagonists |
| 04/07/2010 | EP2170843A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 04/07/2010 | EP2170842A1 Protein kinase inhibitors and methods for using thereof |
| 04/07/2010 | EP2170841A1 Process for introduction of hydroxyethoxy side chain in bosentan |
| 04/07/2010 | EP2170839A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 04/07/2010 | EP2170260A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres |
| 04/07/2010 | EP2170065A1 Diphenyl substituted alkanes |
| 04/07/2010 | EP1971581B1 Piperazine compounds with a herbicidal action |
| 04/07/2010 | EP1635818B1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/07/2010 | EP1597250B1 Indolylmaleimide derivatives |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | EP1551829B1 Novel compounds with antibacterial activity |
| 04/07/2010 | CN1934090B Substituted N-cyclohexyl imidazolinones having an MCH-modulatory effect |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7692027 Process for the preparation of telmisartan |
| 04/06/2010 | US7692024 Gas generant compositions |